CompletedPhase 3

A Study of the Efficacy and Safety of Albiglutide in Subjects With Type 2 Diabetes With Renal Impairment.

NCT01098539

What is this trial?

Generating plain-language summary...

Am I eligible?

Generating eligibility summary...

What's involved?

Summarizing study design...

Where and how to apply

Primary location

GSK Investigational Site

Birmingham, Alabama, United States

+217 additional locations

View on ClinicalTrials.gov

Save this trial

Quick facts

Start date: 2010-05
Enrollment: 507 participants
Sponsor: GlaxoSmithKline
Purpose: treatment

Locations (218)

GSK Investigational SiteBirmingham, Alabama, United States
GSK Investigational SiteGulf Shores, Alabama, United States
GSK Investigational SiteHuntsville, Alabama, United States
GSK Investigational SiteToney, Alabama, United States
GSK Investigational SitePhoenix, Arizona, United States
GSK Investigational SiteFresno, California, United States
GSK Investigational SiteHuntington Beach, California, United States
GSK Investigational SiteLos Angeles, California, United States
GSK Investigational SiteLos Angeles, California, United States
GSK Investigational SiteLos Angeles, California, United States
GSK Investigational SiteLos Gatos, California, United States
GSK Investigational SiteOrange, California, United States
GSK Investigational SiteSan Diego, California, United States
GSK Investigational SiteSan Diego, California, United States
GSK Investigational SiteSan Dimas, California, United States
GSK Investigational SiteTarzana, California, United States
GSK Investigational SiteWest Hills, California, United States
GSK Investigational SiteWhittier, California, United States
GSK Investigational SiteWhittier, California, United States
GSK Investigational SiteDoral, Florida, United States
GSK Investigational SiteHollywood, Florida, United States
GSK Investigational SiteJacksonville, Florida, United States
GSK Investigational SiteMiami, Florida, United States
GSK Investigational SiteMiami Beach, Florida, United States
GSK Investigational SiteNew Port Richey, Florida, United States
GSK Investigational SitePembroke Pines, Florida, United States
GSK Investigational SitePlantation, Florida, United States
GSK Investigational SiteTampa, Florida, United States
GSK Investigational SiteWinter Park, Florida, United States
GSK Investigational SiteWinter Park, Florida, United States
GSK Investigational SiteAtlanta, Georgia, United States
GSK Investigational SiteAtlanta, Georgia, United States
GSK Investigational SiteAugusta, Georgia, United States
GSK Investigational SiteBlue Ridge, Georgia, United States
GSK Investigational SiteDecatur, Georgia, United States
GSK Investigational SiteRoswell, Georgia, United States
GSK Investigational SiteStone Mountain, Georgia, United States
GSK Investigational SiteValparaiso, Indiana, United States
GSK Investigational SiteDes Moines, Iowa, United States
GSK Investigational SiteMission, Kansas, United States
GSK Investigational SiteLexington, Kentucky, United States
GSK Investigational SitePaducah, Kentucky, United States
GSK Investigational SiteAlexandria, Louisiana, United States
GSK Investigational SiteBangor, Maine, United States
GSK Investigational SiteHyattsville, Maryland, United States
GSK Investigational SiteSpringfield, Massachusetts, United States
GSK Investigational SiteDearborn, Michigan, United States
GSK Investigational SiteDetroit, Michigan, United States
GSK Investigational SiteFlint, Michigan, United States
GSK Investigational SiteSaint Clair Shores, Michigan, United States
GSK Investigational SiteTaylor, Michigan, United States
GSK Investigational SiteKansas City, Missouri, United States
GSK Investigational SiteKansas City, Missouri, United States
GSK Investigational SiteSpringfield, Missouri, United States
GSK Investigational SiteOmaha, Nebraska, United States
GSK Investigational SiteLas Vegas, Nevada, United States
GSK Investigational SiteLas Vegas, Nevada, United States
GSK Investigational SiteNorth Massapequa, New York, United States
GSK Investigational SiteStaten Island, New York, United States
GSK Investigational SiteAsheville, North Carolina, United States
GSK Investigational SiteHurst, North Carolina, United States
GSK Investigational SiteShelby, North Carolina, United States
GSK Investigational SiteTabor City, North Carolina, United States
GSK Investigational SiteWilmington, North Carolina, United States
GSK Investigational SiteWinston-Salem, North Carolina, United States
GSK Investigational SiteCincinnati, Ohio, United States
GSK Investigational SiteCleveland, Ohio, United States
GSK Investigational SiteGallipolis, Ohio, United States
GSK Investigational SiteOklahoma City, Oklahoma, United States
GSK Investigational SiteMedford, Oregon, United States
GSK Investigational SiteAltoona, Pennsylvania, United States
GSK Investigational SiteDownington, Pennsylvania, United States
GSK Investigational SitePhiladelphia, Pennsylvania, United States
GSK Investigational SiteCharleston, South Carolina, United States
GSK Investigational SiteColumbia, South Carolina, United States
GSK Investigational SiteGreer, South Carolina, United States
GSK Investigational SiteNorth Myrtle Beach, South Carolina, United States
GSK Investigational SiteTaylors, South Carolina, United States
GSK Investigational SiteBristol, Tennessee, United States
GSK Investigational SiteFranklin, Tennessee, United States
GSK Investigational SiteKnoxville, Tennessee, United States
GSK Investigational SiteTullahoma, Tennessee, United States
GSK Investigational SiteArlington, Texas, United States
GSK Investigational SiteArlington, Texas, United States
GSK Investigational SiteAustin, Texas, United States
GSK Investigational SiteAustin, Texas, United States
GSK Investigational SiteDallas, Texas, United States
GSK Investigational SiteDallas, Texas, United States
GSK Investigational SiteDallas, Texas, United States
GSK Investigational SiteDeer Park, Texas, United States
GSK Investigational SiteFort Worth, Texas, United States
GSK Investigational SiteGrapevine, Texas, United States
GSK Investigational SiteHouston, Texas, United States
GSK Investigational SiteHouston, Texas, United States
GSK Investigational SiteHouston, Texas, United States
GSK Investigational SiteHouston, Texas, United States
GSK Investigational SiteHouston, Texas, United States
GSK Investigational SiteHouston, Texas, United States
GSK Investigational SiteHouston, Texas, United States
GSK Investigational SiteHouston, Texas, United States
GSK Investigational SiteHumble, Texas, United States
GSK Investigational SiteHurst, Texas, United States
GSK Investigational SiteIrving, Texas, United States
GSK Investigational SiteMidland, Texas, United States
GSK Investigational SiteNorth Richland Hills, Texas, United States
GSK Investigational SitePearland, Texas, United States
GSK Investigational SitePlano, Texas, United States
GSK Investigational SiteRichardson, Texas, United States
GSK Investigational SiteSan Antonio, Texas, United States
GSK Investigational SiteSan Antonio, Texas, United States
GSK Investigational SiteSan Antonio, Texas, United States
GSK Investigational SiteSchertz, Texas, United States
GSK Investigational SiteSugarland, Texas, United States
GSK Investigational SiteTomball, Texas, United States
GSK Investigational SiteBountiful, Utah, United States
GSK Investigational SiteSouth Burlington, Vermont, United States
GSK Investigational SiteBurke, Virginia, United States
GSK Investigational SiteManassas, Virginia, United States
GSK Investigational SiteNorfolk, Virginia, United States
GSK Investigational SiteSalem, Virginia, United States
GSK Investigational SiteTacoma, Washington, United States
GSK Investigational SiteGarran, Australian Capital Territory, Australia
GSK Investigational SiteCamperdown, New South Wales, Australia
GSK Investigational SiteAuchenflower, Queensland, Australia
GSK Investigational SiteCaboolture, Queensland, Australia
GSK Investigational SiteHerston, Queensland, Australia
GSK Investigational SiteKippa-Ring, Queensland, Australia
GSK Investigational SiteBox Hill, Victoria, Australia
GSK Investigational SiteClayton, Victoria, Australia
GSK Investigational SiteHeidelberg, Victoria, Australia
GSK Investigational SiteMelbourne, Victoria, Australia
GSK Investigational SiteParkville, Victoria, Australia
GSK Investigational SiteFremantle, Western Australia, Australia
GSK Investigational SitePorto Alegre, Rio Grande do Sul, Brazil
GSK Investigational SiteSão Paulo, São Paulo, Brazil
GSK Investigational SiteBrasília, Brazil
GSK Investigational SiteMogi das Cruzes, Brazil
GSK Investigational SiteBarrangquilla, Colombia
GSK Investigational SiteBogotá, Colombia
GSK Investigational SiteFloridablanca-Santander, Colombia
GSK Investigational SiteBad Nauheim, Hesse, Germany
GSK Investigational SiteBad Lauterberg im Harz, Lower Saxony, Germany
GSK Investigational SiteMainz, Rhineland-Palatinate, Germany
GSK Investigational SiteDresden, Saxony, Germany
GSK Investigational SiteBerlin, State of Berlin, Germany
GSK Investigational SiteAhmedabad, India
GSK Investigational SiteBangalore, India
GSK Investigational SiteBangalore, India
GSK Investigational SiteBangalore, India
GSK Investigational SiteBangalore, India
GSK Investigational SiteBangalore, India
GSK Investigational SiteBelagavi, India
GSK Investigational SiteBelagavi, India
GSK Investigational SiteChennai, India
GSK Investigational SiteLucknow, India
GSK Investigational SiteManipal, India
GSK Investigational SiteMumbai, India
GSK Investigational SiteNashik, India
GSK Investigational SiteAshkelon, Israel
GSK Investigational SiteBeersheba, Israel
GSK Investigational SiteHaifa, Israel
GSK Investigational SiteHaifa, Israel
GSK Investigational SiteHolon, Israel
GSK Investigational SiteKfar Saba, Israel
GSK Investigational SiteSafed, Israel
GSK Investigational SiteArequipa, Arequipa, Peru
GSK Investigational SiteIca, Ica, Peru
GSK Investigational SiteLima, Lima Province, Peru
GSK Investigational SiteLima, Lima Province, Peru
GSK Investigational SiteCallao, Lima, Peru
GSK Investigational SitePiura, Piura, Peru
GSK Investigational SiteLima, Peru
GSK Investigational SiteTrujillo, Peru
GSK Investigational SiteCebu City, Philippines
GSK Investigational SiteIloilo City, Philippines
GSK Investigational SiteMakati City, Philippines
GSK Investigational SitePasay, Philippines
GSK Investigational SiteTagbilaran City, Philippines
GSK Investigational SiteNizhny Novgorod, Russia
GSK Investigational SiteSaratov, Russia
GSK Investigational SiteSt'Petersburg, Russia
GSK Investigational SiteYaroslavl, Russia
GSK Investigational SitePort Elizabeth, Eastern Cape, South Africa
GSK Investigational SiteJohannesburg, Gauteng, South Africa
GSK Investigational SiteJohannesburg, Gauteng, South Africa
GSK Investigational SiteLenasia, Gauteng, South Africa
GSK Investigational SitePretoria, Gauteng, South Africa
GSK Investigational SiteDurban, KwaZulu-Natal, South Africa
GSK Investigational SitePhoenix, KwaZulu-Natal, South Africa
GSK Investigational SiteHoughton Estate, South Africa
GSK Investigational SitePretoria, South Africa
GSK Investigational SiteSomerset West, South Africa
GSK Investigational SiteTygerberg, South Africa
GSK Investigational SiteSeongnam-si, South Korea
GSK Investigational SiteSeoul, South Korea
GSK Investigational SiteSeoul, South Korea
GSK Investigational SiteSeoul, South Korea
GSK Investigational SiteSeoul, South Korea
GSK Investigational SiteSuwon, Kyonggi-do, South Korea
GSK Investigational SiteA Coruña, Spain
GSK Investigational SiteAlicante, Spain
GSK Investigational SiteMálaga, Spain
GSK Investigational SitePalma de Mallorca, Spain
GSK Investigational SiteSantiago de Compostela, Spain
GSK Investigational SiteSeville, Spain
GSK Investigational SiteTorrevieja (Alicante), Spain
GSK Investigational SiteKaohsiung City, Taiwan
GSK Investigational SiteTaichung, Taiwan
GSK Investigational SiteTainan, Taiwan
GSK Investigational SiteCoventry, West Midlands, United Kingdom
GSK Investigational SiteBirmingham, United Kingdom
GSK Investigational SiteHertfordshire, United Kingdom
GSK Investigational SiteHull, United Kingdom
GSK Investigational SiteLiverpool, United Kingdom
GSK Investigational SiteLivingston, United Kingdom
GSK Investigational SiteLondon, United Kingdom
GSK Investigational SitePlymouth, United Kingdom
GSK Investigational SiteSwansea, United Kingdom